National Bank of Canada
TXG icon

National Bank of Canada’s 10x Genomics TXG Stock Holding History

National Bank of Canada’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.61K Buy
170
+132
+347% +$2.64K ﹤0.01% 2521
2025
Q4 		$619 Sell
38
-1,357
-97% -$20.5K ﹤0.01% 2676
2025
Q3 		$16.3K Sell
1,395
-184,612
-99% -$2.41M ﹤0.01% 2204
2025
Q2 		$2.15M Buy
+186,007
New +$1.7M ﹤0.01% 1128
2025
Q1 		– Sell
-105,700
Closed -$1.52M – 3161
2024
Q4 		$1.52M Buy
+105,700
New +$1.67M ﹤0.01% 1223
2024
Q3 		– Sell
-606
Closed -$11.3K – 3048
2024
Q2 		$11.3K Hold
606
– – ﹤0.01% 2102
2024
Q1 		$15.7K Hold
606
– – ﹤0.01% 2080
2023
Q4 		$32.9K Hold
606
– – ﹤0.01% 1896
2023
Q3 		$24.5K Hold
606
– – ﹤0.01% 1987
2023
Q2 		$33.8K Sell
606
-5
-0.8% -$271 ﹤0.01% 1885
2023
Q1 		$34.1K Buy
611
+505
+476% +$23.6K ﹤0.01% 1822
2022
Q4 		$3.86K Sell
106
-500
-83% -$16.3K ﹤0.01% 2383
2022
Q3 		$17K Buy
606
+540
+818% +$20.6K ﹤0.01% 2064
2022
Q2 		$3K Sell
66
-224
-77% -$11.6K ﹤0.01% 2561
2022
Q1 		$22K Hold
290
– – ﹤0.01% 2155
2021
Q4 		$43K Buy
+290
New +$44.4K ﹤0.01% 1925

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada's TXG Position: Q1 2026 in Review

National Bank of Canada increased its 10x Genomics (TXG) stake by 347% in Q1 2026, buying an estimated $2.64K and bringing the position to 170 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

National Bank of Canada first reported a position in TXG in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.15M in Q2 2025. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • National Bank of Canada held 170 shares of 10x Genomics worth $3.61K as of Q1 2026.
  • National Bank of Canada bought 132 10x Genomics shares in Q1 2026, an estimated $2.64K.
  • 10x Genomics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2521 holding.
  • National Bank of Canada first reported a position in 10x Genomics in Q4 2021 and has held it in 16 quarters since.
  • National Bank of Canada's 10x Genomics position peaked at $2.15M in Q2 2025.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.